intra articular only compared with combined intra venous and intra articular tranexamic acid in total perioperative blood loss in primary unilateral total knee arthroplasty a retrospective study

only Compared with Combined Intra-venous and Intra-articular Tranexamic Acid in Total Perioperative Blood Loss in Primary Unilateral Total Knee Arthroplasty: A Retrospective Study. Abstract Background: Intravenous (IV), Intra-Articular (IA) Administration of Tranexamic Acid (TXA) and combined administration of IV and IA TXA for patients who received primary Total Knee Arthroplasty (TKA) have been reported in several literatures. However, IV TXA may cause unwanted side effects as increasing dose. Our study wants to compare the effect in total blood loss of IA TXA only and combined therapy with IA and IV TXA in patients undergoing primary total knee arthroplasty. Methods: The retrospective study included all patients received primary unilateral TKA from May 2014 to June 2016 at Kaohsiung Veterans General Hospital. There were 782 knees included. These knees were divided into three groups: IA TXA only, combined IA and IV TXA, and without TXA using. All patients were operated under spinal or general anesthesia using tourniquet and cemented posterior stabilized type implant. Estimated postoperative blood loss was calculated as OSTHEO Formula. Results: In these 782 knees on the study, there were 566 women (72.38%) and 216 men (27.62%). Mean age was 69.93±8.25 years of age. There was no significant difference over gender and age between these three groups. The group of IA-only showed significant reduced total blood loss compared with the group of combined IA IV TXA (P=0.016) and the group of none of TXA using(P=0.000). Conclusions: Intraoperative intra-articular TXA is an effective and convenient method to reduce total blood loss in the patient undergoing primary TKA and even with better efficacy than perioperative combined therapy of IV and IA TXA in our study.

[1]  J. Seon,et al.  Combined Administration of IV and Topical Tranexamic Acid is Not Superior to Either Individually in Primary Navigated TKA. , 2017, The Journal of arthroplasty.

[2]  R. Markert,et al.  The Assessment of Blood Loss During Total Knee Arthroplasty When Comparing Intravenous vs Intracapsular Administration of Tranexamic Acid. , 2016, The Journal of arthroplasty.

[3]  J. Krishnan,et al.  Blood Loss in Total Knee Arthroplasty , 2016, The Journal of Knee Surgery.

[4]  N. Foss,et al.  Combined Intra-Articular and Intravenous Tranexamic Acid Reduces Blood Loss in Total Knee Arthroplasty: A Randomized, Double-Blind, Placebo-Controlled Trial. , 2016, The Journal of bone and joint surgery. American volume.

[5]  S. Yeo,et al.  Intravenous versus intra-articular tranexamic acid in total knee arthroplasty: A double-blinded randomised controlled noninferiority trial. , 2016, The Knee.

[6]  John S. Lewis,et al.  Impact of perioperative allogeneic and autologous blood transfusion on acute wound infection following total knee and total hip arthroplasty. , 2014, The Journal of bone and joint surgery. American volume.

[7]  B. Kollen,et al.  Autologous re-transfusion drain compared with no drain in total knee arthroplasty: a randomised controlled trial. , 2014, Blood transfusion = Trasfusione del sangue.

[8]  M. Muñoz,et al.  Low vacuum re-infusion drains after total knee arthroplasty: is there a real benefit? , 2014, Blood transfusion = Trasfusione del sangue.

[9]  M. Martínez-Zapata,et al.  Tranexamic acid in orthopedic surgery , 2014 .

[10]  A. Hungin,et al.  Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K). , 2013, The Journal of bone and joint surgery. American volume.

[11]  G. Banfi,et al.  Blood management and transfusion strategies in 600 patients undergoing total joint arthroplasty: an analysis of pre-operative autologous blood donation. , 2013, Blood transfusion = Trasfusione del sangue.

[12]  J. Pawliszyn,et al.  Pharmacokinetics of tranexamic acid in patients undergoing cardiac surgery with use of cardiopulmonary bypass * , 2012, Anaesthesia.

[13]  C. Vielpeau Perioperative bleeding and early mortality in hip and knee surgery. , 2012, Orthopaedics & traumatology, surgery & research : OTSR.

[14]  S. Arabia,et al.  Tranexamic Acid A Review of its Use in the Treatment of Hyperfibrinolysis , 2012 .

[15]  G. Cao,et al.  Analysis on hidden blood loss of total knee arthroplasty in treating knee osteoarthritis , 2011, Chinese medical journal.

[16]  F. Chung,et al.  Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. , 2010, The Journal of bone and joint surgery. American volume.

[17]  D. König,et al.  The effect of computer navigation on blood loss and transfusion rate in TKA. , 2010, Orthopedics.

[18]  Julija Durasek,et al.  [Factors affecting blood loss in total knee arthroplasty patients]. , 2010, Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti.

[19]  J. Douketis,et al.  Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. , 2009, Thrombosis research.

[20]  Ranawat,et al.  Total Knee Arthroplasty for Patients , 2006 .

[21]  M. Parker,et al.  Closed suction drainage for hip and knee arthroplasty. A meta-analysis. , 2004, The Journal of bone and joint surgery. American volume.

[22]  N. Rosencher,et al.  Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe * , 2003, Transfusion.

[23]  C N A Esler,et al.  The use of a closed-suction drain in total knee arthroplasty. A prospective, randomised study. , 2003, The Journal of bone and joint surgery. British volume.

[24]  N. Rosencher,et al.  Orthopaedic Surgery Transfusion Haemoglobin European Overview: the OSTEO study (extended abstract). , 2001, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[25]  E. Vamvakas Transfusion of buffy coat‐depleted blood components and risk of postoperative infection in orthopedic patients , 2000, Transfusion.

[26]  A. Benzer,et al.  Transfusion of buffy coat‐depleted blood components and risk of postoperative infection in orthopedic patients , 1999, Transfusion.

[27]  K. Goa,et al.  Tranexamic acid: a review of its use in surgery and other indications. , 1999, Drugs.

[28]  H. Mallmin,et al.  Postoperative drainage of knee arthroplasty is not necessary: a randomized study of 90 patients. , 1998, Acta orthopaedica Scandinavica.

[29]  L. Goodnough,et al.  A standardized method for calculating blood loss , 1997, Transfusion.

[30]  M. Braga,et al.  A Single Unit of Transfused Allogeneic Blood Increases Postoperative Infections , 1996, Vox sanguinis.

[31]  H. Fredin,et al.  Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients. , 1996, The Journal of bone and joint surgery. British volume.

[32]  J. Ylinen,et al.  Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total knee arthroplasty. , 1995, British journal of anaesthesia.

[33]  P. Lotke,et al.  Blood loss after total knee replacement. Effects of tourniquet release and continuous passive motion. , 1991, The Journal of bone and joint surgery. American volume.

[34]  Z. Goldhaber,et al.  Orthopedic Surgery , 2007 .